Samsung Bioepis Snags Second Soliris Biosimilar In Europe

As Three Generics From Accord And Extrovis Also Receive CHMP Nods

 
• By Dave Wallace
  
EMA
The EMA’s CHMP has endorsed Samsung Bioepis’ eculizumab

More from Biosimilars

More from Products